Becton
Dickinson and Company (U.S.)
Novo Nordisk A/S (Denmark)
Ypsomed Holding AG (Switzerland)
Medtronic plc (Ireland)
Animas Corporation (U.S.)
Tandem Diabetes Care Inc. (U.S.)
Sanofi (France)
Biocon Ltd. (India)
Eli Lilly and Company (U.S.)
and Insulet Corporation (U.S.).
Abbott; and F. Hoffmann-La Roche Ltd.